Menu

Colgate-Palmolive

NYSE: CL

Colgate-Palmolive (CL) is a global consumer products company that sells oral care, personal care, home cleaning products and pet nutrition. Its Oral Care business, led by Colgate toothpaste and toothbrushes, is a major focus for analysts, alongside its Hill’s Pet Nutrition business, which sells specialized food for dogs and cats.

Sector
Consumer Non-Durables
Industry
Household/Personal Care
Employees
33,600
Founded
1806

The forecast figures are tipranks’s, read on 2026-10-27 and linked below.
The company facts and financials are CNN Business’s, read on 2026-11-05 and linked below.

Colgate-Palmolive forecast

The forecast in short

tipranks records 12 analyst ratings on Colgate-Palmolive and summarises them as “Moderate Buy”. Their average 12-month price target is 98.33 (Potential Growth = 5.62%). Its tipranks score is 7 out of 10 — Neutral. These are tipranks’s figures as read on 2026-10-27, not CariBroker’s own view, and nothing here is advice to buy or sell.

Market cap

USD 78.58 B

≈ RM 321.43 B

Share price

USD 98.85

≈ RM 404.36 · 18 Nov close

#333World ranking

tipranks score

Neutral

7

Analyst ratings

Moderate Buy

  • Buy867%
  • Hold433%
  • Sell00%

tipranks’s own summary of the 12 ratings above.

12 months price forecast

98.33 Potential Growth = 5.62%

USD 74.16USD 85.74USD 97.32USD 108.9Past 12 months12 months forecastHighUSD 106AverageUSD 98.33LowUSD 872025-102026-10

As tipranks publishes it. CariBroker has not recalculated any of it.

Financials

Q3 earnings, quarter ending Sep 29, 2026

MeasureQ3 20261-year change
Total revenue5.37B2.66% up
Net income751.00M2,129.73% up
Earnings per share0.943.52% up
Net profit margin13.99%2.35% down
Free cash flow1.04B18.73% down
Debt-to-equity ratio26.79172.40% up

Revenue and net income, last 4 quarters

-$2.0B$0.0$2.0B$4.0B$6.0BQ4 2025Q1 2026Q2 2026Q3 2026

Total revenueNet income

Analyst profiles: who made each call, and when

AnalystFromPositionTarget priceDated
Andrea Faria TeixeiraJ.P. MorganBuyUSD 1042026-10-19
Lauren LiebermanBarclaysHoldUSD 872026-10-16
Peter GromUBSBuyUSD 1062026-10-15
Peter GalboBank of America SecuritiesBuyUSD 1002026-10-09
Nik ModiRBC CapitalBuyUSD 1042026-10-06
Show all 18
AnalystFromPositionTarget priceDated
Christopher CareyWells FargoHoldUSD 902026-10-05
Bonnie HerzogGoldman SachsBuyUSD 1002026-10-05
Michael LaveryPiper SandlerBuyUSD 952026-09-21
Unknown AnalystBernsteinHoldUSD 992026-09-15
Robert MoskowTD CowenHoldUSD 902026-08-03
Stephen PowersDeutsche BankBuyUSD 1012026-08-03
Dara MohsenianMorgan StanleyBuyUSD 1042026-08-03
Filippo FalorniCitiBuyUSD 1102026-07-14
Taylor ConradArgus ResearchHoldN/A2026-06-09
Robert OttensteinEvercore ISIBuyUSD 1002026-06-08
Andy SimDBSHoldUSD 952026-05-03
Kaumil GajrawalaJefferiesHoldUSD 882026-04-21
Edward LewisRothschild & Co RedburnBuyUSD 1002026-04-21

Investment strengths

Free Cash Flow Generation

Consistent, large free cash flow (TTM ~$3.86B) funds dividends, buybacks and debt service, enabling durable capital allocation. Strong operating cash flow (~$4.46B) supports investment in brands, innovation and working capital, and provides a buffer through cycles.

Emerging Markets Revenue Strength

Broad-based organic growth led by emerging markets (mid-single digits) and standout country performance (India double-digits) diversifies revenue sources. Geographic breadth reduces dependence on any single economy and supports more stable long-term top-line growth.

Hill's Premium Pet Franchise

Hill's operates as a premium, higher-margin franchise with therapeutic and wet segments growing and e-commerce momentum. Its pricing power, clinical positioning and category mix offer durable structural tailwinds and a stable profit contributor over time.

People also ask

What is the 12-month price target for Colgate-Palmolive (CL)?

tipranks publishes an average 12-month price target of 98.33 (Potential Growth = 5.62%), as read on 2026-10-27. The highest target is USD 106 and the lowest is USD 87. A price target is an analyst’s estimate of where a share might trade, not a promise, and CariBroker gives no investment advice.

See tipranks’s own page ↗

How many analysts cover Colgate-Palmolive (CL)?

tipranks records 12 analyst ratings: 8 buy, 4 hold and 0 sell, which it summarises as “Moderate Buy”, as read on 2026-10-27.

See tipranks’s own page ↗

What is the tipranks score for Colgate-Palmolive (CL)?

tipranks scores it 7 out of 10 and calls that “Neutral”, as read on 2026-10-27. The score is tipranks’s, not CariBroker’s, and CariBroker does not rate listed shares.

See tipranks’s own page ↗

Is this CariBroker’s own forecast for Colgate-Palmolive?

No. Every figure on this page is published by tipranks, copied on 2026-10-27 with a link to the original, and not recalculated. CariBroker checks financial companies in Malaysia against the public registers; it makes no forecast of its own and holds no licence to advise on securities.

See tipranks’s own page ↗

Disclaimer

CariBroker provides information only and does not provide investment, financial or legal advice.

All investment ideas

Check another company

Search every bank, broker and alert list in one place